Oct 23, 2026 10:16AM
Oct 23, 2026 10:15AM
Oct 19, 2026 06:02AM
Oct 18, 2026 06:05PM
Aug 6, 2026 04:05PM
Jul 23, 2026 07:27AM
Jul 17, 2026 04:15PM Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
May 27, 2026 04:05PM
May 27, 2026 04:05PM
May 21, 2026 05:39PM
May 21, 2026 05:39PM
May 12, 2026 04:05PM
May 5, 2026 08:00AM
May 5, 2026 08:00AM Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
Apr 21, 2026 10:27AM
Apr 17, 2026 03:15PM
Apr 17, 2026 03:15PM
Apr 10, 2026 02:48PM
Apr 9, 2026 08:03AM
Apr 9, 2026 08:00AM
Mar 27, 2026 06:07AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Mar 27, 2026 06:02AM
Mar 26, 2026 04:05PM
Jan 6, 2026 08:12AM
Jan 6, 2026 08:00AM
Nov 10, 2025 04:05PM
Oct 13, 2025 04:07PM
Oct 13, 2025 04:05PM Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Aug 6, 2025 04:05PM
May 14, 2025 04:05PM
Apr 28, 2025 08:00AM
Mar 27, 2025 07:54AM
Mar 26, 2025 04:05PM
Mar 15, 2025 11:25AM
Jan 30, 2025 06:40AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $10 at H.C. Wainwright
Jan 29, 2025 07:09AM
Jan 29, 2025 07:00AM
Jan 9, 2025 07:00AM
Sep 16, 2024 12:18PM
Sep 16, 2024 11:55AM
Sep 16, 2024 07:01AM
Sep 16, 2024 07:00AM Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
Aug 9, 2024 07:00AM
Jun 20, 2024 06:10AM
Jun 18, 2024 02:19PM
Jun 18, 2024 01:32PM
Jun 18, 2024 12:13PM
Jun 18, 2024 11:58AM
Jun 18, 2024 07:32AM Zentalis Pharmaceuticals (ZNTL) Resumes Trading, Down 29%
Jun 18, 2024 07:00AM

335,360 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All